Display options
Share it on

Results Pharma Sci. 2011 May 17;1(1):1-10. doi: 10.1016/j.rinphs.2011.05.003. eCollection 2011 May.

Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, Avicel and Aerosil.

Results in pharma sciences

Subrata Mallick, Saroj Kumar Pradhan, Muronia Chandran, Manoj Acharya, Tanmayee Digdarsini, Rajaram Mohapatra

Affiliations

  1. Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan University, Kalinganagar, Bhubaneswar 751003, Orissa, India.
  2. Department of Pharmaceutics, College of Pharmaceutical Sciences, Berhampur, Mohuda, Orissa, India.

PMID: 25755976 PMCID: PMC4150624 DOI: 10.1016/j.rinphs.2011.05.003

Abstract

Particle rearrangements, compaction under pressure and in vitro dissolution have been evaluated after melt dispersion of ibuprofen, Avicel and Aerosil. The Cooper-Eaton and Kuno equations were utilized for the determination of particle rearrangement and compression behavior from tap density and compact data. Particle rearrangement could be divided into two stages as primary and secondary rearrangement. Transitional tapping between the stages was found to be 20-25 taps in ibuprofen crystalline powder, which was increased up to 45 taps with all formulated powders. Compaction in the rearrangement stages was increased in all the formulations with respect to pure ibuprofen. Significantly increased compaction of ibuprofen under pressure can be achieved using Avicel by melt dispersion technique, which could be beneficial in ibuprofen tablet manufacturing by direct compression. SEM, FTIR and DSC have been utilized for physicochemical characterization of the melt dispersion powder materials. Dissolution of ibuprofen from compacted tablet of physical mixture and melt dispersion particles has also been improved greatly in the following order: Ibc

Keywords: Aerosil lubricated mcc; Compression behavior; Ibuprofen; In vitro dissolution; Melt dispersion; Particle rearrangement

References

  1. Eur J Pharm Biopharm. 2009 Feb;71(2):395-401 - PubMed
  2. Pharm Dev Technol. 2001 Nov;6(4):563-72 - PubMed
  3. Acta Pharm. 2006 Dec;56(4):451-61 - PubMed
  4. Int J Pharm. 2002 Sep 5;244(1-2):45-57 - PubMed
  5. Drug Dev Ind Pharm. 1999 Mar;25(3):297-305 - PubMed
  6. Eur J Pharm Sci. 2005 May;25(1):41-8 - PubMed
  7. Drug Dev Ind Pharm. 2004 Jan;30(1):43-51 - PubMed
  8. Chem Pharm Bull (Tokyo). 2007 Jul;55(7):985-91 - PubMed
  9. Int J Pharm. 2007 Oct 1;343(1-2):228-37 - PubMed
  10. Pak J Pharm Sci. 2010 Jul;23(3):284-90 - PubMed
  11. Drug Dev Ind Pharm. 2008 Jul;34(7):781-8 - PubMed
  12. Eur J Pharm Biopharm. 2008 Feb;68(2):346-51 - PubMed
  13. Int J Pharm. 2003 Aug 11;261(1-2):57-67 - PubMed
  14. J Pharm Sci. 1989 Jan;78(1):68-72 - PubMed
  15. Pharm Res. 1994 Apr;11(4):575-9 - PubMed
  16. Pharm Res. 1991 Nov;8(11):1377-83 - PubMed
  17. Eur J Pharm Biopharm. 2002 Sep;54(2):107-17 - PubMed
  18. Pharm Dev Technol. 2001;6(2):193-200 - PubMed
  19. Int J Pharm. 2003 Apr 14;255(1-2):33-42 - PubMed

Publication Types